View drug registration information details.
Items | Registration information |
ID | 384 |
No | 384 |
Brand Name | FAT EMULSION, AMINO ACIDS (17) AND GLUCOSE (11%) INJECTION |
Ingredients | ANHYDROUS GLUCOSE 97G, ALANINE 4.8 G, ARGININE 3.4, ASPARTIC ACID 1G, PHENYLALAMINE 2.4 G, GLUTAMIC ACID 1.7, GLYCINE 2.4G, HISTIDINE 2G, ISOLEUCINE 1.7G, LEUCINE 2.4G, LYSINE HYDROCHLORIDE 3.4G, METHIONINE 1.7G, PROLINE 2G, SERINE 1.4G, THREONINE 1.7G, TRYPTOPHAN 0.57G, TYROSINE 0.069G, VALINE 2.2G, SODIUM GLYCEROPHOSPHATE 1.5G, CALCIUM CHLORIDE 0.22G, POTASSIUM CHLORIDE 1.8 G, MAGNESIUM SULFATE 0.48G, SODIUM ACETATE 1.5 G, SOYBEAN OIL 51G |
Dosage Form | EMULSION FOR INFUSION |
Primary Packaging | BAG |
Storage | STORE BELOW 25 C, DO NOT FREEZE |
Shelf Life | 2 YEARS |
Pack Size | 1440 ML/BAG |
Dispensing Category | Prescription only |
ATC Classification | B05BA10 |
Pharmaceutical Class | ESSENTIAL FATTY ACID, PROTEIN AND ELECTROLYTE |
Indications | AS A SOURCE OF CALORIES, PROTEIN, ELECTROLYTES AND ESSENTIAL FATTY ACID FOR ADULT PATIENTS REQUIRING PARENTERAL NUTRITION WHEN ORAL OR ENTERAL NUTRITION IS NOT POSSIBLE, INSUFFICIENT OR CONTRAINDICATED. IT MAYBE USED TO PREVENT ESSENTIAL FATTY ACID DEFICIENCY OR TREAT NEGATIVE NITROGEN BALANCE IN ADULT PATIENTS |
Contraindications | PATIENTS WITH KNOWN HYPERSENSITIVITY TO EGG, SOYBEAN, PEANUT, OR ANY OF THE ACTIVE OR INACTIVE INGREDIENT IN THE PRODUCT, PATIENT WITH SEVERE DISORDER OF LIPID METABOLISM CHARACTERIZED BY HYPERTRIGLYCERIDEMIA |
Side Effects | |
Unit Price | 11 |
EDL |
No |
Description | GLUCOSE INJECTION CHAMBER: A COLORLESS OR ALMOST COLORLESS CLEAR LIQUID. AMINO ACID INJECTION CHAMBER: A COLORLESS TO PALE YELLOW CLEAR LIQUID. FAT EMULSION INJECTION CHAMBER: A WHITE EMULSION |
Note | |
License Owner | NAKORNLUANG PHARMA EXPORT-IMPORT CO.,LTD |
Manufacturer | SICHUAN KELUN PHARMACEUTICAL CO.,LTD |
Country | CHINA |
Import Registration No | GYZZ H20173381 |
Import Registration Date | 2023-12-12 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-04-26 |
FDD Registration No | 12 I 5826/24 |
FDD Registration Date | 2024-12-16 |
Expiry Date | 2029-12-15 |
Back to drug list
|